Access to Data: Dr Bridge had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Bridge, Greenhouse, Kelleher.
Acquisition of data: Bridge, Weldon.
Analysis and interpretation of data: Bridge, Greenhouse, Weldon, Campo, Kelleher.
Drafting of the manuscript: Bridge, Greenhouse.
Critical revision of the manuscript for important intellectual content: Bridge, Greenhouse, Weldon, Campo, Kelleher.
Statistical analysis: Bridge, Greenhouse.
Obtained funding: Bridge, Greenhouse, Kelleher.
Administrative, technical, or material support: Bridge, Weldon.
Study supervision: Bridge, Greenhouse, Kelleher.
Financial Disclosures: Dr Bridge reported that from 2001 to 2004, he participated as a coinvestigator of an open-label trial of citalopram for treatment of pediatric recurrent abdominal pain. The study was funded by an investigator-initiated grant from Forest Laboratories (John Campo, MD, Principal Investigator). Dr Bridge reported having received no financial support from Forest Laboratories or from Dr Campo for his participation; salary support to Dr Bridge was provided by National Institute of Mental Health grants MH55123 and subsequently MH66371 (Advanced Center for Interventions and Services Research for Early-Onset Mood and Anxiety Disorder, David Brent, MD, Principal Investigator). Dr Campo reported having received past grant support from Forest Laboratories and having served as a consultant to Eli Lilly. No other financial disclosures were reported.
Funding/Support: Dr Bridge was supported by grant K01-MH069948 from the National Institute of Mental Health, National Institutes of Health. Drs Greenhouse and Kelleher were supported by grant 5R01-MH078629-02 and Dr Campo by grant R01 MH069715-04 from the National Institute of Mental Health, National Institutes of Health.
Role of the Sponsor: The National Institute of Mental Health had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.